Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advanced disease
Open Access
- 1 September 2008
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 19 (suppl_7) , vii195-vii199
Abstract
J. Giralt, S. Benavente, M. Arguis; Optimizing approaches to head and neck cancer: strengths and weaknesses in multidisciplinary treatments of locally advancedKeywords
This publication has 33 references indexed in Scilit:
- Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck CancerNew England Journal of Medicine, 2007
- The multidisciplinary meeting: An indispensable aid to communication between different specialitiesEuropean Journal of Cancer, 2006
- Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2006
- Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all?Head & Neck, 2005
- Effect of process standards on survival of patients with head and neck cancer in the south and west of EnglandBritish Journal of Cancer, 2004
- Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancerHead & Neck, 2004
- Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?Head & Neck, 2003
- Neck dissection following radiochemotherapy of advanced head and neck cancer – for selected cases only?Radiotherapy and Oncology, 2003
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998